Pharmaceutical company Moderna will apply for US and European emergency authorization for its co vid 19 vaccine on Monday after the company said full results from a late stage study showed it was 94.1% effective with no serious safety concerns.

Madonna also reported that its vaccine efficacy rate was consistent across age, race, ethnicity and gender demographics, as well as having a 100% success rate in preventing severe cases of a disease that has killed nearly 1.5 million people worldwide.

After seeing the results, Modern is chief medical officer told Reuters.

He became overwhelmed with emotion, saying Quote, It was the first time I allowed myself to cry at this level of effectiveness.

When you just do the math of what it means for the pandemic that's raging around us, it's just overwhelming.

Madonna is the second company to seek emergency use authorization after Pfizer, which reported that its vaccine made in conjunction with beyond Tech, had a 95% efficacy rate.

In an interview on CBS this morning Monday, Health and Human Services Secretary Alex Azar said it wouldn't be long before those most vulnerable, like nursing home residents and frontline healthcare workers would be receiving the vaccines.

We could be seeing both of these vaccines out on getting into people's arms before Christmas.

Madonna's distribution is expected to be easier than Pfizer's because while Madonna's vaccine needs to be stored in a freezer, it does not require the ultra cold temperature that fighters does.

In addition to filing its U.

S application, Madonna said it would seek conditional approval from the European Medicines Agency, which is already reviewing its data.

Moderna shares jumped to a record high on Monday, a rise of more than 600% this year.